Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML [Phase 2, Phase 3]
A Phase 2/3 clinical trial is evaluating L-Annamycin for Injection in combination with cytarabine as second-line remission induction therapy…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial) [Phase 2]
A Phase 2 clinical trial evaluating venetoclax or placebo with reduced-intensity conditioning hematopoietic cell transplant followed by main…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
Prospective collection, storage, and reporting of data on patients undergoing hematopoietic stem cell transplantation using a standard prepa…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of JNJ-89853413 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms [Phase 1]
Phase 1 clinical trial update announcing JNJ-89853413 for relapsed or refractory acute myeloid leukemia and myelodysplastic neoplasms, curre…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies [Phase 1]
A Phase 1 study is evaluating ICP-248 in combination with azacitidine for myeloid malignancies, including acute myeloid leukemia and myelody…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation [NA]
This entry notes a clinical trial exploring an eHealth mindfulness-based music therapy intervention for patients undergoing stem cell transp…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes [Phase 1, Phase 2]
A Phase 1/2 study of CTX-712 in relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic syndromes is currently recruiting…
-
CLINICAL_TRIALS other · 2026-04-13Clinical Trial Update: Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia [NA]
Clinical trial evaluating brain MRI feasibility (Brain MRF) in children, adolescents, and young adults with acute leukemia is currently susp…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
A multicenter protocol to improve access and distribution of unlicensed cryopreserved cord blood units, with the study currently recruiting.…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: VAH vs VA in Newly Diagnosed Elderly AML [Phase 3]
Phase 3 clinical trial comparing VAH versus VA in newly diagnosed elderly patients with acute myeloid leukemia; the study status is not yet …
-
FDA approval · 2026-04-09FDA Approved: ONUREG — Supplemental Application (Celgene Corporation)
FDA approved a supplemental application for ONUREG (azacitidine) to support its use in maintenance therapy for adults with acute myeloid leu…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML [Phase 3]
A Phase 3 trial comparing crenolanib to midostaurin after induction and consolidation chemotherapy in newly diagnosed FLT3-mutated acute mye…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML) [Phase 1]
This Phase 1 clinical trial is evaluating high-dose ascorbate in combination with azacitidine and venetoclax for Acute Myeloid Leukemia. The…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML [Phase 3]
Phase 3 clinical trial updating a study of Ziftomenib in combination with venetoclax and azacitidine or standard 7+3 induction for newly dia…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: ABC Maintenance Therapy for AML [NA]
A clinical trial update indicates a not-yet-recruiting study of ABC Maintenance Therapy for acute myeloid leukemia in remission.
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokinetics of Oral Cladribine With the Reference Listed Drug, Intravenous Cladribine [Phase 1]
Phase 1 open-label bioavailability study comparing pharmacokinetics of oral cladribine with intravenous cladribine. The study status is TERM…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Motixafortide for MRD Sensitization in AML [Phase 2]
A Phase 2 clinical trial of motixafortide for sensitizing measurable residual disease in acute myeloid leukemia is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia [Phase 1]
Phase 1 trial evaluating the combination of atezolizumab with allogeneic natural killer cell therapy in adults with relapsed or refractory a…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: First-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome (HR-MDS) [Phase 1]
Genmab announced a first-in-human Phase 1 trial of GEN3018 in relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic syn…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Phase I Clinical Trial of ThINKK Adoptive Immunotherapy After Allogeneic Hematopoietic Transplantation in Children With Leukemia or Neuroblastoma [Phase 1]
Phase I clinical trial update for ThINKK Adoptive Immunotherapy after allogeneic hematopoietic stem cell transplantation in children with ac…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome [Phase 1]
Phase 1 clinical trial evaluating BMS-986497 (ORM-6151) as monotherapy and in dual/triple combinations with azacitidine and venetoclax in re…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults [NA]
Overview of the my.naviGATE guide for after-treatment effects in adolescents and young adults with sarcoma and related cancers; the study is…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia. [Phase 3]
A Phase 3 randomized pragmatic trial named IMPACT-AML is investigating relapsed or refractory acute myeloid leukemia and is currently recrui…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia [Phase 1]
A Phase 1 trial evaluating AOH1996 in relapsed or refractory acute myeloid leukemia is currently suspended.
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating Vyxeos as re-induction therapy for acute myeloid leukemia in patients with persistent disease af…